FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Syndicate content

ADHD related Press Releases

Supernus Pharmaceuticals Raises $42 Million to Prepare for Launch of Product Candidates in Epilepsy and Develop Pipeline i

Posted January 6, 2012

Two Transactions in December Bring Total Raised in Non-Dilutive Financing to More Than $165 Million ROCKVILLE, Md.--(BUSINESS WIRE)-- Supernus Pharmaceuticals, Inc. today announced that in December Read more...

Shire Announces Strategic Partnership for ADHD Medicines in Japan With Shionogi & Co., Ltd.

Posted November 18, 2011

Shionogi and Shire to jointly develop and commercialize ADHD medicines in JapanNYON, Switzerland and PHILADELPHIA, November 18, 2011 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global Read more...

FDA Issues Safety Communication about an Ongoing Review of Stimulant Medications Used in Children with ADHD

Posted June 16, 2009

For Immediate Release: June 15, 2009 FDA Issues Safety Communication about an Ongoing Review of Stimulant Medications Used in Children with ADHD There may be an association between the use of

Read more...

PRESS RELEASE: AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications

Posted November 12, 2007

AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive Read more...

FDA STATEMENT: AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications

Posted September 18, 2007

AHRQ and FDA to Collaborate in Largest Study Ever of Possible Heart Risks With ADHD Medications Two U.S. Department of Health and Human Services agencies will collaborate in the most comprehensive Read more...